For example, Zepbound can cost $45 to $65 per month with certain Kaiser Permanente Federal Employee Health Benefits (FEHB) plans
Semaglutide is beneficial for patients at risk of cardiovascular events, while Zepbound may be preferable for those avoiding thyroid-related risks
This drug, with promising results for NASH-related biomarkers, 55 is under evaluation in a phase 2 study (SYNERGY-NASH, NCT04166773), with the primary outcome being the absence of NASH and no worsening of fibrosis on liver histology after 1 year of treatment
"It helps in stopping smoking." (Male, 16 months on GLP-1 therapy) "It helped me stop smoking without any withdrawal symptoms, and thank God, I don't think about going back." (Male, 24 months on GLP-1 therapy) A temporary perceived reduction in cravings was also highlighted, with some participants noting that the effect diminished after discontinuing the medication